Suppr超能文献

Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents.

作者信息

Tock Lian, Dâmaso Ana R, de Piano Aline, Carnier June, Sanches Priscila L, Lederman Henrique Manoel, Ernandes Regina M Y, de Mello Marco Túlio, Tufik Sérgio

机构信息

Post Graduate Program of Nutrition, Paulista Medicine School, Federal University of São Paulo, UNIFESP-EPM, 04020-060 São Paulo, Brazil.

出版信息

J Obes. 2010;2010. doi: 10.1155/2010/831901. Epub 2010 Feb 9.

Abstract

Objective. To assess the long-term effects of metformin in combination with lifestyle intervention and its association between insulin levels and the degree of steatosis at ultrasonography (US) in obese adolescents. Methods. Thirty-five postpubertal obese boys were randomized into two groups: one receiving metformin in combination with a multidisciplinary lifestyle intervention versus a placebo group, which also received the same intervention. The visceral, subcutaneous fat and degree of steatosis were measured by ultrasonography. Fasting blood samples were collected to analyze glucose, insulin, insulin resistance, and aminotransferases. Repeated ANOVA measures were used to compare changes over time and between groups, and Spearman's correlations were used to identify an association between insulin and the degree of steatosis at US. Results. There was a positive correlation between the degree of steatosis at US with insulin concentrations and HOMA-IR. Long-term therapy plus metformin significantly reduced body weight, body mass index, insulin, HOMA-IR, and visceral fat. Conclusions. Metformin was more effective than the placebo in improving clinical parameters associated with obesity and steatosis.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f31f/2925435/bbcc1b251b3a/JOBES2010-831901.001.jpg

相似文献

9
Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.
Pediatr Diabetes. 2009 Feb;10(1):5-13. doi: 10.1111/j.1399-5448.2008.00450.x. Epub 2008 Aug 20.
10
Hepatic steatosis in obese Chinese children.
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1257-63. doi: 10.1038/sj.ijo.0802734.

引用本文的文献

5
Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
Pharmaceuticals (Basel). 2018 Nov 8;11(4):121. doi: 10.3390/ph11040121.
6
The effects of metformin on simple obesity: a meta-analysis.
Endocrine. 2018 Dec;62(3):528-534. doi: 10.1007/s12020-018-1717-y. Epub 2018 Aug 27.
7
Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling Pathway.
Evid Based Complement Alternat Med. 2017;2017:6178358. doi: 10.1155/2017/6178358. Epub 2017 Aug 28.
8
Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3).
Mol Pharm. 2015 Dec 7;12(12):4301-10. doi: 10.1021/acs.molpharmaceut.5b00501. Epub 2015 Nov 16.
10
Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.
World J Gastroenterol. 2014 Sep 14;20(34):12182-201. doi: 10.3748/wjg.v20.i34.12182.

本文引用的文献

1
Cardiovascular risk factors, their associations and presence of metabolic syndrome in adolescents.
J Pediatr (Rio J). 2009 Jan-Feb;85(1):55-60. doi: 10.2223/JPED.1867.
2
Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.
Pediatr Diabetes. 2008 Dec;9(6):567-76. doi: 10.1111/j.1399-5448.2008.00434.x. Epub 2008 Aug 27.
3
Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.
Pediatr Diabetes. 2009 Feb;10(1):5-13. doi: 10.1111/j.1399-5448.2008.00450.x. Epub 2008 Aug 20.
4
Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.
Hepatology. 2008 Aug;48(2):449-57. doi: 10.1002/hep.22350.
5
Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents.
Dig Liver Dis. 2008 Feb;40(2):132-9. doi: 10.1016/j.dld.2007.09.009. Epub 2007 Dec 21.
6
Non-alcoholic fatty-liver disease in pediatric populations.
J Pediatr Endocrinol Metab. 2007 Oct;20(10):1059-73. doi: 10.1515/jpem.2007.20.10.1059.
7
Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin.
Acta Paediatr. 2007 Sep;96(9):1326-32. doi: 10.1111/j.1651-2227.2007.00429.x.
8
Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease.
J Pediatr Gastroenterol Nutr. 2007 Apr;44(4):446-52. doi: 10.1097/MPG.0b013e31803815d9.
10
Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy.
Eur J Gastroenterol Hepatol. 2006 Dec;18(12):1241-5. doi: 10.1097/01.meg.0000243872.86949.95.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验